187 related articles for article (PubMed ID: 37034360)
1. Anti-Jo1 Syndrome: Understanding a Rare Cause of Interstitial Lung Disease.
Hegde A; Marwah V; V S; Choudhary R; Malik V
Mediterr J Rheumatol; 2022 Dec; 33(4):437-443. PubMed ID: 37034360
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
[TBL] [Abstract][Full Text] [Related]
4. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
5. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
[TBL] [Abstract][Full Text] [Related]
6. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
7. Antisynthetase Syndrome With Predominant Pulmonary Involvement: A Case Report.
Lima Corrêa de Araújo B; Victor DR; Farias Fontes HM; Caminha Mendes Gomes RM; Lima Corrêa de Araújo L
Cureus; 2023 Aug; 15(8):e43966. PubMed ID: 37746430
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.
Trallero-Araguás E; Grau-Junyent JM; Labirua-Iturburu A; García-Hernández FJ; Monteagudo-Jiménez M; Fraile-Rodriguez G; Les-Bujanda I; Rodriguez-Carballeira M; Sáez-Comet L; Selva-O'Callaghan A;
Semin Arthritis Rheum; 2016 Oct; 46(2):225-231. PubMed ID: 27139168
[TBL] [Abstract][Full Text] [Related]
9. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.
Bartoloni E; Gonzalez-Gay MA; Scirè C; Castaneda S; Gerli R; Lopez-Longo FJ; Martinez-Barrio J; Govoni M; Furini F; Pina T; Iannone F; Giannini M; Nuño L; Quartuccio L; Ortego-Centeno N; Alunno A; Specker C; Montecucco C; Triantafyllias K; Balduzzi S; Sifuentes-Giraldo WA; Paolazzi G; Bravi E; Schwarting A; Pellerito R; Russo A; Selmi C; Saketkoo LA; Fusaro E; Parisi S; Pipitone N; Franceschini F; Cavazzana I; Neri R; Barsotti S; Codullo V; Cavagna L
Autoimmun Rev; 2017 Mar; 16(3):253-257. PubMed ID: 28147261
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome.
Notarnicola A; Preger C; Lundström SL; Renard N; Wigren E; Van Gompel E; Galindo-Feria AS; Persson H; Fathi M; Grunewald J; Jakobsson PJ; Gräslund S; Lundberg IE; Fernandes-Cerqueira C
Arthritis Res Ther; 2022 Mar; 24(1):62. PubMed ID: 35236390
[TBL] [Abstract][Full Text] [Related]
11. [Acute interstitial lung disease revealing antisynthetase syndrome].
Bizien N; Renault A; Boles JM; Delluc A
Rev Pneumol Clin; 2011 Dec; 67(6):367-70. PubMed ID: 22137282
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study.
Sodsri T; Petnak T; Ngamjanyaporn P
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959314
[TBL] [Abstract][Full Text] [Related]
13. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
[TBL] [Abstract][Full Text] [Related]
14. Anti-synthetase syndrome presenting with interstitial lung disease.
Athanassiou P; Kostopoulos M; Tzanavari A; Spyridis A; Kostoglou-Athanassiou I
Mediterr J Rheumatol; 2017 Dec; 28(4):212-216. PubMed ID: 32185286
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
Johnson C; Connors GR; Oaks J; Han S; Truong A; Richardson B; Lechtzin N; Mammen AL; Casciola-Rosen L; Christopher-Stine L; Danoff SK
Respir Med; 2014 Oct; 108(10):1542-8. PubMed ID: 25269710
[TBL] [Abstract][Full Text] [Related]
16. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
18. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
Huang HL; Lin WC; Yeh CC; Sun YT
J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).
Rojas-Serrano J; Herrera-Bringas D; Mejía M; Rivero H; Mateos-Toledo H; Figueroa JE
Clin Rheumatol; 2015 Sep; 34(9):1563-9. PubMed ID: 26219488
[TBL] [Abstract][Full Text] [Related]
20. Clinical heterogeneity and outcomes of antisynthetase syndrome.
Hervier B; Benveniste O
Curr Rheumatol Rep; 2013 Aug; 15(8):349. PubMed ID: 23794106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
